HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David E Jane Selected Research

GluN2C-2D antagonist UBP145

10/2011Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David E Jane Research Topics

Disease

7Epilepsy (Aura)
12/2021 - 12/2010
4Nervous System Diseases (Neurological Disorders)
06/2015 - 05/2009
3Schizophrenia (Dementia Praecox)
10/2017 - 12/2010
2Mental Disorders (Mental Disorder)
01/2019 - 11/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2015 - 09/2012
2Chronic Pain
06/2015 - 12/2010
1Alzheimer Disease (Alzheimer's Disease)
06/2015
1Cognitive Dysfunction
01/2013
1Neuralgia (Stump Neuralgia)
09/2012
1Thrombotic Stroke
10/2011
1Glioma (Gliomas)
12/2010
1Pain (Aches)
12/2010
1Stroke (Strokes)
12/2010
1Amnesia (Dissociative Amnesia)
03/2006

Drug/Important Bio-Agent (IBA)

4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019 - 12/2010
2Glutamic Acid (Glutamate)FDA Link
06/2015 - 11/2013
2LigandsIBA
04/2013 - 12/2010
2Kainic Acid Receptors (Kainate Receptor)IBA
12/2010 - 03/2006
1Neuroprotective AgentsIBA
12/2021
1arctigeninIBA
11/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2015
1Pharmaceutical PreparationsIBA
01/2013
1CoumarinsIBA
09/2012
1GluN2C-2D antagonist UBP145IBA
10/2011
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
12/2010
1Glutamate Receptors (Glutamate Receptor)IBA
05/2009